El interés en corto de Avid Bioservices da a los inversores una idea del grado en que los inversores apuestan por la caída de las acciones de Avid Bioservices. Los datos de interés en corto se actualizan cada dos semanas.

Avid Bioservices (NASDAQ:CDMO) Bolsa, Informe de interés en corto

Avid Bioservices

Avid Bioservices Inc is a clinical-stage biopharmaceutical company focused on the development and Current Good Manufacturing Practices (CGMP) of biopharmaceutical products derived from mammalian cell culture. Its business is organized into one reportable operating segment which is contract manufacturing and development services segment. Its services include clinical and commercial drug substance manufacturing, bulk packaging, release and stability testing and regulatory submissions support. The company also provides a variety of process development services including cell line development, upstream and downstream development and optimization, analytical method development, testing and characterization.

Avid Bioservices Inc

<p>Truist Securities  analyst Tobey Sommer   maintains Brink's (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/BCO#NYSE">BCO</a>) with a Buy and lowers the price target from $144 to $138.</p>


News

Price Target

Analyst Ratings

Truist Securities Maintains Buy on Brink's, Lowers Price Target to $138

<p><strong>Air Products &amp; Chemicals Inc</strong> (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/APD#NYSE">APD</a>) reported <a target="_blank" href="https://www.benzinga.com/pressreleases/24/11/n41800447/air-products-reports-fiscal-2024-fourth-quarter-gaap-eps-of-8-81-and-adjusted-eps-of-3-56" rel="noreferrer noopener">fourth-quarter 2024</a> adjusted EPS of $3.56, beating the consensus of $3.48.</p>
<p>Quarterly sales reached $3.187 billion, a slight 0.10% year-over-year decline, missing the $3.21 billion consensus, as volume and price gains were offset by lower energy cost pass-through.</p>
<p>Sales by segments: Americas $1.307 billion (-3% YoY), Europe $730.9 million (+3% YoY), and Asia $861.2 million (+7% YoY).</p>
<p>Operating income for the quarter rose to $2.424 billion from $738.6 million a year ago, and the margin expanded to 76.1%, up from 23.1% a year ago.</p>
<p>Adjusted EBITDA rose 12% YoY to $1.4 billion, with margins expanding 460 basis points to 44.1%. Air Products&#8217; operating cash flow for the fiscal totaled $3.646 billion, up from $3.205 billion in 2023.</p>
<p>Fiscal 2024 sales declined 4% YoY to $12.10 billion, while adjusted EPS rose 8% to $12.43.</p>
<p><strong>Q1 Guidance:</strong> Air Products expects Adjusted EPS of $2.75 to $2.85 versus the consensus of $3.20.</p>
<p><strong>2025 Guidance: </strong>Air Products sees Adjusted EPS of $12.70-$13.00 versus a consensus of $12.33 and a capital expenditures outlook of $4.5 billion &#8211; $5.0 billion.</p>
<p>Air Products Chairman, President, and Chief Executive Officer Seifi Ghasemi commented, &#8220;We also completed the strategic divestiture of the LNG business at the end of September, demonstrating our commitment to our core industrial gas business while providing clean hydrogen at scale to serve significant demand in the heavy transportation and industrial sectors.&#8221;</p>
<p>&#8220;Air Products also continues to generate strong and steady cash flow that supports disciplined capital allocation and our long history of returning cash to shareholders. This year, we expect to pay out approximately $1.6 billion in dividends to our shareholders.&#8221;</p>
<p><strong>Price Action:</strong> APD shares are trading higher by 3.33% at $316.93 at the last check Thursday.</p>


Earnings

Guidance

Air Products Reports Mixed Q4 With EPS Gains, Revenue Miss, And Solid Cash Flow

<p>Barrington Research  analyst Michael Petusky   maintains US Physical Therapy (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/USPH#NYSE">USPH</a>) with a Outperform and maintains $108 price target.</p>


USPH

Barrington Research Maintains Outperform on US Physical Therapy, Maintains $108 Price Target

<p>Top Kingwin Ltd (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/WAI#NASDAQ">WAI</a>) is pleased to announce that its subsidiary, Guji Technology (Shenzhen) Co., Ltd., has achieved a significant milestone by generating RMB 2million in revenue in October 2024.&nbsp;<br /><br /><br /><br />Top Kingwin Ltd remains committed to investing in its subsidiaries and expanding its hardware sales portfolio to enhance shareholder value. The company looks forward to building on this momentum as it continues to execute its strategic initiatives.</p>


Top Kingwin Ltd's Subsidiary, Guji Technology, Achieves RMB 2Million In Revenue For October 2024

<p>Benchmark  analyst Michael Ward   reiterates Lyft (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/LYFT#NASDAQ">LYFT</a>) with a Hold.</p>


Reiteration

LYFT

Benchmark Reiterates Hold on Lyft

<p>The Q3 earnings report for <strong>Hyatt Hotels</strong> (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/H#NYSE">H</a>) was released on Thursday, October 31, 2024 at 06:55 AM.</p>
<p>Here's what investors need to know about the latest announcement.</p>
<h3>Earnings</h3>
<p>Hyatt Hotels missed estimated earnings by -32.0%, reporting an EPS of $0.94 versus an estimate of $1.38.</p>
<p>Revenue was up $7.00 million from the same period last year.</p>
<h3>Performance in Previous Earnings</h3>
<p>The company beat on EPS by $0.36 in the previous quarter, leading to a 1.0% drop share price change the next day.</p>
<p>Here's a look at Hyatt Hotels's past performance:</p>
<p>
<table>
<thead>
<tr>
<th><strong>Quarter</strong></th>
<th><strong>Q3 2024</strong></th>
<th><strong>Q2 2024</strong></th>
<th><strong>Q1 2024</strong></th>
<th><strong>Q4 2023</strong></th>
<th><strong>Q3 2023</strong></th>
</tr>
</thead>
<tbody>
<tr>
<td><strong>EPS Estimate</strong></td>
<td>1.38</td>
<td>1.17</td>
<td>0.92</td>
<td>0.39</td>
<td>0.62</td>
</tr>
<tr>
<td><strong>EPS Actual</strong></td>
<td>0.94</td>
<td>1.53</td>
<td>0.71</td>
<td>0.64</td>
<td>0.70</td>
</tr>
<tr>
<td><strong>Revenue Estimate</strong></td>
<td>1.57B</td>
<td>1.74B</td>
<td>1.71B</td>
<td>1.60B</td>
<td>1.64B</td>
</tr>
<tr>
<td><strong>Revenue Actual</strong></td>
<td>1.63B</td>
<td>1.70B</td>
<td>1.71B</td>
<td>1.66B</td>
<td>1.62B</td>
</tr>
</tbody>
</table>
</p>
<h3>Peer Performance in Recent Earnings</h3>
<p>With Hyatt Hotels's earnings data now available, it's crucial to gauge how its competitors, including Norwegian Cruise Line, Viking Holdings, and Global Business Travel, have been performing.</p>
<ul>
<li>Norwegian Cruise Line's earnings announcement on October 31, 2024 exceeded expectations, with an actual EPS of $0.99 compared to the market's projected EPS of $0.94, resulting in a 5.32% increase.</li>
<li>Viking Holdings announced earnings on August 22, 2024, revealing results below market expectations. Despite the market's anticipation of an EPS of $0.65, Viking Holdings's actual EPS was $0.37, resulting in a -43.08% decrease compared to expectations.</li>
<li>Despite market projections of an EPS of $-0.03, Global Business Travel's earnings on November 05, 2024 fell short with an actual EPS of $-0.28, representing a -833.33% decrease from expectations.</li>
</ul>
<h3>Comprehensive Analysis: Competitors' Quarterly Earnings and Stock Performance</h3>
<p>This insightful analysis provides an overview of the market's responses to the latest earnings releases from key competitors. It presents the projected and actual earnings per share (EPS) figures for each company, alongside the associated stock prices at the close of the announcement day and the opening of the following trading day.</p>
<p>
<table>
<thead>
<tr>
<th><strong>Company Name</strong></th>
<th><strong>Date</strong></th>
<th style="text-align: right;"><strong>EPS Expected</strong></th>
<th style="text-align: right;"><strong>EPS Announced</strong></th>
<th><strong>EPS Change Percent</strong></th>
<th><strong>Stock Price At Close</strong></th>
<th><strong>Stock Price at Next Day Open</strong></th>
<th><strong>Price Change Percent</strong></th>
</tr>
</thead>
<tbody>
<tr>
<td>Hyatt Hotels</td>
<td>October 31, 2024</td>
<td style="text-align: right;">1.38</td>
<td style="text-align: right;">0.94</td>
<td>-31.88%</td>
<td>$145.45</td>
<td>$145.42</td>
<td>-0.02%</td>
</tr>
<tr>
<td>Norwegian Cruise Line</td>
<td>October 31, 2024</td>
<td style="text-align: right;">0.94</td>
<td style="text-align: right;">0.99</td>
<td>5.32%</td>
<td>$25.34</td>
<td>$25.25</td>
<td>-0.36%</td>
</tr>
<tr>
<td>Viking Holdings</td>
<td>August 22, 2024</td>
<td style="text-align: right;">0.65</td>
<td style="text-align: right;">0.37</td>
<td>-43.08%</td>
<td>$33.22</td>
<td>$33.83</td>
<td>1.84%</td>
</tr>
<tr>
<td>Global Business Travel</td>
<td>November 05, 2024</td>
<td style="text-align: right;">-0.03</td>
<td style="text-align: right;">-0.28</td>
<td>-833.33%</td>
<td>$7.73</td>
<td>$7.87</td>
<td>1.81%</td>
</tr>
</tbody>
</table>
</p>
<h3>Delving into Peer Revenue Comparison: Estimated vs. Announced</h3>
<p>Here is a comparison table showing estimated and announced revenue figures for Hyatt Hotels's peers. This comparison offers insights into the revenue performance of these companies, giving valuable context for understanding their financial standing within the industry.</p>
<p>
<table>
<thead>
<tr>
<th><strong>Company Name</strong></th>
<th><strong>Estimated Revenue</strong></th>
<th><strong>Announced Revenue</strong></th>
<th><strong>Revenue Surprise Percentage</strong></th>
</tr>
</thead>
<tbody>
<tr>
<td>Hyatt Hotels</td>
<td>1.57B</td>
<td>1.63B</td>
<td>3.76%</td>
</tr>
<tr>
<td>Norwegian Cruise Line</td>
<td>2.77B</td>
<td>2.81B</td>
<td>1.34%</td>
</tr>
<tr>
<td>Viking Holdings</td>
<td>1.43B</td>
<td>1.59B</td>
<td>10.98%</td>
</tr>
<tr>
<td>Global Business Travel</td>
<td>613.53M</td>
<td>597M</td>
<td>-2.69%</td>
</tr>
</tbody>
</table>
</p>
<p>To track all earnings releases for Hyatt Hotels <a href="https://www.benzinga.com/quote/H/earnings">visit their earnings calendar here.</a> </p>
<p>This article was generated by Benzinga's automated content engine and reviewed by an editor.</p>


Hyatt Hotels Q3 Earnings Assessment

<p><strong>Welltower</strong> (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/WELL#NYSE">WELL</a>) just disclosed its Q3 earnings on Monday, October 28, 2024 at 04:05 PM.</p>
<p>Here's a brief overview of the earnings report.</p>
<h3>Earnings</h3>
<p>Welltower beat estimated earnings by 7.000000000000001%, reporting an EPS of $1.11 versus an estimate of $1.04.</p>
<p>Revenue was up $394.00 million from the same period last year.</p>
<h3>Overview of Past Earnings</h3>
<p>The company beat on EPS by $0.04 in the previous quarter, leading to a 1.0% increase share price change the next day.</p>
<p>Here's a look at Welltower's past performance:</p>
<p>
<table>
<thead>
<tr>
<th><strong>Quarter</strong></th>
<th><strong>Q3 2024</strong></th>
<th><strong>Q2 2024</strong></th>
<th><strong>Q1 2024</strong></th>
<th><strong>Q4 2023</strong></th>
<th><strong>Q3 2023</strong></th>
</tr>
</thead>
<tbody>
<tr>
<td><strong>EPS Estimate</strong></td>
<td>1.04</td>
<td>1.01</td>
<td>0.94</td>
<td></td>
<td></td>
</tr>
<tr>
<td><strong>EPS Actual</strong></td>
<td>1.11</td>
<td>1.05</td>
<td>1.01</td>
<td>0.96</td>
<td>0.92</td>
</tr>
<tr>
<td><strong>Revenue Estimate</strong></td>
<td>1.95B</td>
<td>1.89B</td>
<td>1.81B</td>
<td>1.75B</td>
<td>1.63B</td>
</tr>
<tr>
<td><strong>Revenue Actual</strong></td>
<td>2.06B</td>
<td>1.82B</td>
<td>1.56B</td>
<td>1.75B</td>
<td>1.66B</td>
</tr>
</tbody>
</table>
</p>
<p>New investors should note that it is sometimes not an earnings beat or miss that most affects the price of a stock, but the guidance (or forecast).</p>
<h3>Guidance</h3>
<p>Welltower management provided guidance for FY 2024, expecting earnings between $4.27 and $4.33 per share.</p>
<h3>Competitors' Recent Earnings Updates</h3>
<p>When analyzing Welltower's numbers, it's imperative to put them into context by comparing them to those of its competitors, like Healthpeak Properties, Sabra Health Care REIT, and National Health Investors.</p>
<ul>
<li>Healthpeak Properties's earnings on October 24, 2024 exceeded market projections, revealing an EPS of $0.45 compared to the estimated EPS of $0.44, resulting in a 2.27% increase.</li>
<li>The latest earnings announcement from Sabra Health Care REIT on October 31, 2024 exceeded expectations, with an actual EPS of $0.35 compared to the market's estimate of $0.35, resulting in a 0.0% increase.</li>
<li>On November 05, 2024, National Health Investors unveiled earnings that were below market expectations, with an actual EPS of $1.03 compared to an estimated EPS of $1.08, resulting in a -4.63% decrease.</li>
</ul>
<h3>Insights into Competitors' Quarterly Earnings and Stock Performance</h3>
<p>This analysis provides insights into the market's response to the latest earnings releases of key competitors. It highlights the expected and announced earnings per share (EPS) for each company, along with the corresponding stock prices at the close of the announcement day and the open of the following trading day.</p>
<p>
<table>
<thead>
<tr>
<th><strong>Company Name</strong></th>
<th><strong>Date</strong></th>
<th style="text-align: right;"><strong>EPS Expected</strong></th>
<th style="text-align: right;"><strong>EPS Announced</strong></th>
<th><strong>EPS Change Percent</strong></th>
<th><strong>Stock Price At Close</strong></th>
<th><strong>Stock Price at Next Day Open</strong></th>
<th><strong>Price Change Percent</strong></th>
</tr>
</thead>
<tbody>
<tr>
<td>Welltower</td>
<td>October 28, 2024</td>
<td style="text-align: right;">1.04</td>
<td style="text-align: right;">1.11</td>
<td>6.73%</td>
<td>$130.57</td>
<td>$133.62</td>
<td>2.34%</td>
</tr>
<tr>
<td>Healthpeak Properties</td>
<td>October 24, 2024</td>
<td style="text-align: right;">0.44</td>
<td style="text-align: right;">0.45</td>
<td>2.27%</td>
<td>$23.0</td>
<td>$22.66</td>
<td>-1.48%</td>
</tr>
<tr>
<td>Sabra Health Care REIT</td>
<td>October 31, 2024</td>
<td style="text-align: right;">0.35</td>
<td style="text-align: right;">0.35</td>
<td>0.0%</td>
<td>$19.4</td>
<td>$19.78</td>
<td>1.96%</td>
</tr>
<tr>
<td>National Health Investors</td>
<td>November 05, 2024</td>
<td style="text-align: right;">1.08</td>
<td style="text-align: right;">1.03</td>
<td>-4.63%</td>
<td>$76.73</td>
<td>$76.75</td>
<td>0.03%</td>
</tr>
</tbody>
</table>
</p>
<h3>Comparative Overview of Peer Revenues: Estimated vs. Announced</h3>
<p>Below is a comparison of estimated and announced revenue figures for Welltower's peers. This comparison gives insights into the revenue performance of these companies, providing valuable context for understanding their financial standing within the industry.</p>
<p>
<table>
<thead>
<tr>
<th><strong>Company Name</strong></th>
<th><strong>Estimated Revenue</strong></th>
<th><strong>Announced Revenue</strong></th>
<th><strong>Revenue Surprise Percentage</strong></th>
</tr>
</thead>
<tbody>
<tr>
<td>Welltower</td>
<td>1.95B</td>
<td>2.06B</td>
<td>5.44%</td>
</tr>
<tr>
<td>Healthpeak Properties</td>
<td>688.98M</td>
<td>700.40M</td>
<td>1.66%</td>
</tr>
<tr>
<td>Sabra Health Care REIT</td>
<td>172.34M</td>
<td>178.00M</td>
<td>3.28%</td>
</tr>
<tr>
<td>National Health Investors</td>
<td>79.21M</td>
<td>82.94M</td>
<td>4.72%</td>
</tr>
</tbody>
</table>
</p>
<p>To track all earnings releases for Welltower <a href="https://www.benzinga.com/quote/WELL/earnings">visit their earnings calendar here.</a> </p>
<p>This article was generated by Benzinga's automated content engine and reviewed by an editor.</p>


WELL

Welltower Earnings Review: Q3 Summary

<p>Shares of <strong>Nvidia Corporation</strong> (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/NVDA#NASDAQ">NVDA</a>) settled higher on Wednesday after <strong>Donald Trump</strong> won the election <a href="https://www.benzinga.com/news/24/11/41780976/chip-stocks-like-nvidia-broadcom-taiwan-semi-gain-after-trump-win-whats-going-on">to become the 47th U.S. president.</a></p>
<p>The Biden administration imposed an artificial intelligence technology embargo on China, restricting the country's access to sophisticated AI chips from Nvidia, citing national security threats.</p>
<p>With the recent buzz around Nvidia ahead of quarterly earnings, some investors may also be eyeing potential gains from the company's dividends. As of now, Nvidia offers an annual dividend yield of 0.03%. That&#8217;s a quarterly dividend amount of 1 cent per share (4 cents a year).</p>
<p>To figure out how to earn $500 monthly from Nvidia, we start with the yearly target of $6,000 ($500 x 12 months).</p>
<p>Next, we take this amount and divide it by Nvidia's 4 cent dividend: $6,000 / $0.04 = 150,000 shares.</p>
<p><strong>So, an investor would need to own approximately $21,841,500 worth of Nvidia, or 150,000 shares to generate a monthly dividend income of $500.</strong></p>
<p><strong>Assuming a more conservative goal of $100 monthly ($1,200 annually), we do the same calculation: $1,200 / $0.04 = 30,000 shares, or $4,368,300 to generate a monthly dividend income of $100.</strong></p>
<p>Note that dividend yield can change on a rolling basis, as the dividend payment and the stock price both fluctuate over time.</p>
<p>The dividend yield is calculated by dividing the annual dividend payment by the current stock price. As the stock price changes, the dividend yield will also change.</p>
<p>For example, if a stock pays an annual dividend of $2 and its current price is $50, its dividend yield would be 4%. However, if the stock price increases to $60, the dividend yield would decrease to 3.33% ($2/$60).</p>
<p>Conversely, if the stock price decreases to $40, the dividend yield would increase to 5% ($2/$40).</p>
<p>Further, the dividend payment itself can also change over time. That can also impact the dividend yield. If a company increases its dividend payment, the dividend yield will increase even if the stock price remains the same. Similarly, if a company decreases its dividend payment, the dividend yield will decrease.</p>
<p><strong>NVDA Price Action:</strong> Shares of Nvidia gained by 4.1% to close at $145.61 on Wednesday.</p>
<p><figure class="wp-block-embed is-type-video is-provider-youtube wp-block-embed-youtube wp-embed-aspect-16-9 wp-has-aspect-ratio"><br />
<div class="wp-block-embed__wrapper">
<iframe loading="lazy" title="How to Find Dividend Stocks: Scan, Analyze, and Capture with Benzinga Pro" width="500" height="281" src="https://www.youtube.com/embed/pVF0O2lsEH4?feature=oembed" frameborder="0" allow="accelerometer; autoplay; clipboard-write; encrypted-media; gyroscope; picture-in-picture; web-share" referrerpolicy="strict-origin-when-cross-origin" allowfullscreen></iframe>
</div>
<p></p></figure></p>
<p><strong>Read More: </strong></p>
<ul>
<li><strong><a href="https://www.benzinga.com/trading-ideas/long-ideas/24/11/41776764/jim-cramer-this-financial-stock-is-a-buy-likes-broadcom">Jim Cramer: This Financial Stock Is A Buy, Likes Broadcom</a></strong></li>
</ul>
<p><em>Image: Shutterstock</em></p>


Long Ideas

Markets

Trading Ideas

NVDA

How To Earn $500 A Month From Nvidia Stock After Trump Win

<p>Performance Shipping (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/PSHG#NASDAQ">PSHG</a>) reported quarterly earnings of $0.32 per share which beat the analyst consensus estimate of $0.25 by 28 percent. This is a 18.52 percent increase over earnings of $0.27 per share from the same period last year.  The company reported quarterly sales of $22.89 million which beat the analyst consensus estimate of $21.59 million by 5.99 percent.  This is a 5.08 percent decrease over sales of $24.11 million the same period last year.</p>


Earnings Beats

PSHG

Performance Shipping Q3 EPS $0.32 Beats $0.25 Estimate, Sales $22.89M Beat $21.59M Estimate

<p>Diamondback Energy (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/FANG#NASDAQ">FANG</a>) has outperformed the market over the past 5 years by 4.82% on an annualized basis producing an average annual return of 18.67%. Currently, Diamondback Energy has a market capitalization of $53.66 billion. </p>
<p><strong>Buying $100 In FANG:</strong> If an investor had bought $100 of FANG stock 5 years ago, it would be worth <strong>$239.15</strong> today based on a price of $183.29 for FANG at the time of writing.</p>
<h3>Diamondback Energy's Performance Over Last 5 Years</h3>
<p><img src="https://www.benzinga.com/files/images/story/2024/1730989829_0.png" alt="comp_fig" /></p>
<p>Finally -- what's the point of all this? The key insight to take from this article is to note how much of a difference compounded returns can make in your cash growth over a period of time.</p>
<p><em>This article was generated by Benzinga's automated content engine and reviewed by an editor.</em></p>


FANG

$100 Invested In Diamondback Energy 5 Years Ago Would Be Worth This Much Today

<p>Global Payments (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/GPN#NYSE">GPN</a>) has outperformed the market over the past 20 years by 2.77% on an annualized basis producing an average annual return of 11.16%. Currently, Global Payments has a market capitalization of $29.27 billion. </p>
<p><strong>Buying $100 In GPN:</strong> If an investor had bought $100 of GPN stock 20 years ago, it would be worth <strong>$821.71</strong> today based on a price of $115.04 for GPN at the time of writing.</p>
<h3>Global Payments's Performance Over Last 20 Years</h3>
<p><img src="https://www.benzinga.com/files/images/story/2024/1730989824_0.png" alt="comp_fig" /></p>
<p>Finally -- what's the point of all this? The key insight to take from this article is to note how much of a difference compounded returns can make in your cash growth over a period of time.</p>
<p><em>This article was generated by Benzinga's automated content engine and reviewed by an editor.</em></p>


If You Invested $100 In This Stock 20 Years Ago, You Would Have $800 Today

<p>Truist Securities  analyst Joel Fishbein   maintains Rapid7 (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/RPD#NASDAQ">RPD</a>) with a Hold and lowers the price target from $40 to $38.</p>


Truist Securities Maintains Hold on Rapid7, Lowers Price Target to $38

<p>EF Hutton  analyst Jason Kolbert   maintains Imunon (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/IMNN#NASDAQ">IMNN</a>) with a Buy and maintains $29 price target.</p>


IMNN

EF Hutton Maintains Buy on Imunon, Maintains $29 Price Target

<p>Truist Securities  analyst Terry Tillman   reiterates Q2 Holdings (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/QTWO#NYSE">QTWO</a>) with a Buy and raises the price target from $78 to $100.</p>


QTWO

Truist Securities Reiterates Buy on Q2 Holdings, Raises Price Target to $100

<p>Truist Securities  analyst Neal Dingmann   maintains Northern Oil &amp; Gas (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/NOG#NYSE">NOG</a>) with a Buy and raises the price target from $44 to $51.</p>


Truist Securities Maintains Buy on Northern Oil & Gas, Raises Price Target to $51

<p>Bill Gates has been impressively named one of the world's richest people for decades. He famously topped the list from 1995 to 2017, holding<a href="https://www.benzinga.com/personal-finance/24/07/39600675/bill-gates-was-the-worlds-richest-man-for-a-record-18-years-his-secret-to-success-saving-like-a-"> the number-one spot for 18</a> out of 23 years.</p>
<p>According to Forbes, Gates&#8217;s net worth is currently around $103 billion. He certainly knows a thing or two about extreme wealth. Yet, in an honest moment, he shared a refreshingly down-to-earth perspective on what money truly brings.</p>
<p><strong>Don't Miss:</strong></p>
<ul>
<li><a href="https://www.benzinga.com/money/are-you-rich"><strong>Are you rich?</strong></a><strong> Here&#8217;s what Americans think you need to be considered wealthy.</strong></li>
<li><a href="https://www.benzinga.com/money/100k-cd"><strong>$100K Sitting In A CD Account, Should I Move Money Into The Stock Market?</strong></a></li>
</ul>
<p>Speaking to students at the University of Washington, Gates highlighted that while millions of dollars provide "meaningful freedom," the difference between having a substantial amount and having billions is not as life-changing as it might seem. "I can understand wanting to have millions of dollars; there's a certain freedom, meaningful freedom, that comes with that," Gates said. But he added a surprising twist: "Once you get much beyond that, I have to tell you, it's the same hamburger. Dick's [Drive-In] has not raised their prices enough."</p>
<p><strong>Trending: Warren Buffett once said, "If you don't find a way to make money while you sleep, you will work until you die." </strong><a href="https://www.benzinga.com/money/connect-invest-real-estate-notes"><strong>These high-yield real estate notes that pay 7.5% &#8211; 9% make earning passive income easier than ever.</strong></a></p>
<p>This comment reflects Gates' outlook that, beyond a certain point, more money doesn't necessarily buy you a better life or greater happiness. It might mean access to luxury, but for daily life, he suggests that the experience remains pretty simple – like eating a burger, no matter how rich you are.</p>
<p><strong>Gates' Legacy of Wealth and Philanthropy</strong></p>
<p>Since cofounding Microsoft, Gates has built an empire that has made him one of the world's wealthiest individuals. But Gates has long expressed a desire to use his wealth for meaningful impact. He even vowed to drop off the billionaires list entirely and in 2024, he dropped to his <a href="https://www.benzinga.com/real-estate/24/05/38588551/bill-gates-is-reportedly-selling-a-pair-of-yachts-after-dropping-to-his-lowest-rank-on-the-billionai">lowest rank in 34 years</a>. Through the Bill &amp; Melinda Gates Foundation, he's donated billions toward health, education and poverty reduction worldwide, focusing on initiatives he believes can change lives more effectively than luxury purchases.</p>
<p><strong>Trending: Many are using this retirement income calculator to check if they&#8217;re on pace —</strong><a href="https://www.benzinga.com/money/how-do-i-calculate-my-retirement-income-adv"><strong> </strong><strong>here&#8217;s a breakdown on how on what&#8217;s behind this formula.</strong></a></p>
<p>Gates' message to students about the relative value of wealth – how, beyond basic freedom, it doesn't change the fundamentals of life – adds depth to his philanthropic philosophy. By emphasizing that money only goes so far in creating happiness or meaning, Gates highlights a belief in using wealth to make a difference rather than simply accumulating more.</p>
<p>In his words, being ambitious and successful is a good thing, but beyond that, it's about finding purpose and "picking what you enjoy doing." Gates' statement invites a look at wealth from a different angle, suggesting that what we choose to do with our resources – and why – matters far more than the size of our bank accounts.&nbsp;</p>
<p><strong>See Also: Invest in $20+ trillion home equity market today across cities like Austin, Miami, and Los Angeles through a </strong><a href="https://www.benzinga.com/money/nada-cityfunds"><strong>unique 5-year term fund targeting a 14-20% IRR with minimums as low as $2,500</strong></a></p>
<p>Although money may not mean much beyond a certain point to Bill Gates, ensuring you have enough to live comfortably is always nice. <a href="https://www.benzinga.com/money/can-you-guess-how-many-americans-successfully-retire-with-1-million-saved">Consulting a financial advisor</a> can help ensure you're on track to meeting your money goals, whether becoming a millionaire or just enjoying all the "hamburgers" you want.&nbsp;</p>
<p><strong>Read Next:</strong></p>
<ul>
<li><strong>‘Scrolling to UBI': Deloitte's #1 fastest-growing software company allows users to earn money on their phones –</strong><a href="https://www.benzinga.com/money/mode-mobile-2"><strong> </strong><strong>invest today with $1,000 for just $0.25/share</strong></a></li>
<li><strong>According to Vanguard&#8217;s Advisor&#8217;s Alpha Study, working with a financial advisor can result in approximately 3% higher net returns annually,</strong><a href="https://www.benzinga.com/money/3-percent-advantage-financial-advisor"><strong> </strong><strong>here are the benefits of partnering with a financial advisor and how to find the right one near you in minutes.</strong></a></li>
</ul>


Personal Finance

Bill Gates Says Being A Billionaire Is Overrated – Being Rich Brings You Freedom, But Beyond That 'It's The Same Hamburger'

<p>Truist Securities  analyst Robyn Karnauskas   maintains Merck &amp; Co (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/MRK#NYSE">MRK</a>) with a Buy and lowers the price target from $132 to $130.</p>


Truist Securities Maintains Buy on Merck & Co, Lowers Price Target to $130

Halliburton Says For North America, Expect FY24 Revenue Decline At The Low End Of Prior Guidance; Expects Capital Expenditures To Be About 6.4% Of Revenue For The Full Year

<p>Barrington Research  analyst Alexander Paris   maintains Franklin Covey (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/FC#NYSE">FC</a>) with a Outperform and maintains $45 price target.</p>


Barrington Research Maintains Outperform on Franklin Covey, Maintains $45 Price Target

<p>The earnings results for <strong>Hyatt Hotels</strong> (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/H#NYSE">H</a>) for Q3 were made public on Thursday, October 31, 2024 at 06:55 AM.</p>
<p>Here's a comprehensive overview of the announcement.</p>
<h3>Earnings</h3>
<p>Hyatt Hotels missed estimated earnings by -32.0%, reporting an EPS of $0.94 versus an estimate of $1.38.</p>
<p>Revenue was up $7.00 million from the same period last year.</p>
<h3>Analysis of Past Earnings</h3>
<p>In the previous quarter, the company beat on EPS by $0.36, resulting in a 1.0% drop change in the share price the following day.</p>
<p>Here's a look at Hyatt Hotels's past performance:</p>
<p>
<table>
<thead>
<tr>
<th><strong>Quarter</strong></th>
<th><strong>Q3 2024</strong></th>
<th><strong>Q2 2024</strong></th>
<th><strong>Q1 2024</strong></th>
<th><strong>Q4 2023</strong></th>
<th><strong>Q3 2023</strong></th>
</tr>
</thead>
<tbody>
<tr>
<td><strong>EPS Estimate</strong></td>
<td>1.38</td>
<td>1.17</td>
<td>0.92</td>
<td>0.39</td>
<td>0.62</td>
</tr>
<tr>
<td><strong>EPS Actual</strong></td>
<td>0.94</td>
<td>1.53</td>
<td>0.71</td>
<td>0.64</td>
<td>0.70</td>
</tr>
<tr>
<td><strong>Revenue Estimate</strong></td>
<td>1.57B</td>
<td>1.74B</td>
<td>1.71B</td>
<td>1.60B</td>
<td>1.64B</td>
</tr>
<tr>
<td><strong>Revenue Actual</strong></td>
<td>1.63B</td>
<td>1.70B</td>
<td>1.71B</td>
<td>1.66B</td>
<td>1.62B</td>
</tr>
</tbody>
</table>
</p>
<h3>Competitors that recently released earnings</h3>
<p>In light of Hyatt Hotels's earnings release, it's crucial to evaluate its performance relative to industry peers, including Norwegian Cruise Line, Viking Holdings, and Global Business Travel.</p>
<ul>
<li>Norwegian Cruise Line's earnings announcement on October 31, 2024 exceeded expectations, with an actual EPS of $0.99 compared to the market's projected EPS of $0.94, resulting in a 5.32% increase.</li>
<li>Viking Holdings announced earnings on August 22, 2024, revealing results below market expectations. Despite the market's anticipation of an EPS of $0.65, Viking Holdings's actual EPS was $0.37, resulting in a -43.08% decrease compared to expectations.</li>
<li>Global Business Travel reported earnings on November 05, 2024 that fell short of expectations, with an actual EPS of $-0.28 compared to the market's estimate of $-0.03, resulting in a -833.33% decrease.</li>
</ul>
<h3>Insights: Competitors' Quarterly Earnings and Stock Performance</h3>
<p>In this detailed analysis, insights are provided into the market's response to the latest earnings releases of key competitors. It highlights the expected and announced earnings per share (EPS) for each company, along with their corresponding stock prices at the close of the announcement day and the open of the following trading day.</p>
<p>
<table>
<thead>
<tr>
<th><strong>Company Name</strong></th>
<th><strong>Date</strong></th>
<th style="text-align: right;"><strong>EPS Expected</strong></th>
<th style="text-align: right;"><strong>EPS Announced</strong></th>
<th><strong>EPS Change Percent</strong></th>
<th><strong>Stock Price At Close</strong></th>
<th><strong>Stock Price at Next Day Open</strong></th>
<th><strong>Price Change Percent</strong></th>
</tr>
</thead>
<tbody>
<tr>
<td>Hyatt Hotels</td>
<td>October 31, 2024</td>
<td style="text-align: right;">1.38</td>
<td style="text-align: right;">0.94</td>
<td>-31.88%</td>
<td>$145.45</td>
<td>$145.42</td>
<td>-0.02%</td>
</tr>
<tr>
<td>Norwegian Cruise Line</td>
<td>October 31, 2024</td>
<td style="text-align: right;">0.94</td>
<td style="text-align: right;">0.99</td>
<td>5.32%</td>
<td>$25.34</td>
<td>$25.25</td>
<td>-0.36%</td>
</tr>
<tr>
<td>Viking Holdings</td>
<td>August 22, 2024</td>
<td style="text-align: right;">0.65</td>
<td style="text-align: right;">0.37</td>
<td>-43.08%</td>
<td>$33.22</td>
<td>$33.83</td>
<td>1.84%</td>
</tr>
<tr>
<td>Global Business Travel</td>
<td>November 05, 2024</td>
<td style="text-align: right;">-0.03</td>
<td style="text-align: right;">-0.28</td>
<td>-833.33%</td>
<td>$7.73</td>
<td>$7.87</td>
<td>1.81%</td>
</tr>
</tbody>
</table>
</p>
<h3>Peer Revenue Comparison: Estimated vs. Announced Revenue</h3>
<p>Here's a comparison table presenting estimated and announced revenue figures for Hyatt Hotels's peers. This comparison offers insights into the revenue performance of these companies, providing valuable context for understanding their financial standing within the industry.</p>
<p>
<table>
<thead>
<tr>
<th><strong>Company Name</strong></th>
<th><strong>Estimated Revenue</strong></th>
<th><strong>Announced Revenue</strong></th>
<th><strong>Revenue Surprise Percentage</strong></th>
</tr>
</thead>
<tbody>
<tr>
<td>Hyatt Hotels</td>
<td>1.57B</td>
<td>1.63B</td>
<td>3.76%</td>
</tr>
<tr>
<td>Norwegian Cruise Line</td>
<td>2.77B</td>
<td>2.81B</td>
<td>1.34%</td>
</tr>
<tr>
<td>Viking Holdings</td>
<td>1.43B</td>
<td>1.59B</td>
<td>10.98%</td>
</tr>
<tr>
<td>Global Business Travel</td>
<td>613.53M</td>
<td>597M</td>
<td>-2.69%</td>
</tr>
</tbody>
</table>
</p>
<p>To track all earnings releases for Hyatt Hotels <a href="https://www.benzinga.com/quote/H/earnings">visit their earnings calendar here.</a> </p>
<p>This article was generated by Benzinga's automated content engine and reviewed by an editor.</p>


Earnings Summary: Hyatt Hotels Q3

Avid Bioservices, Inc. (CDMO) Q1 2025 Earnings Call Transcript

In a report released yesterday, Sean Dodge from RBC Capital maintained a Buy rating on Avid Bioservices (CDMO – Research Report), with a price targ...

RBC Capital Sticks to Its Buy Rating for Avid Bioservices (CDMO)

Avid Bioservices stock rallies 18% after reporting increased backlog

Avidity Biosciences: Good Prospects, But We Are A Little Late

Avid Bioservices ( ($CDMO) ) has shared an update. At Avid Bioservices' 2024 Annual Meeting, stockholders approved significant amendments to the 20...

Avid Bioservices' Strategic Shareholder and Governance Updates

16:55 EST Avid Bioservices (CDMO) trading halted, news pending Published first on TheFly – the ultimate source for real-time, market-moving breakin...

Avid Bioservices trading halted, news pending

18:35 EST Avid Bioservices (CDMO) trading resumes Published first on TheFly – the ultimate source for real-time, market-moving breaking financial n...

Avid Bioservices trading resumes

Avid Bioservices (CDMO), GHO Capital Partners LLP and Ampersand Capital Partners announced they have entered into a definitive merger agreement for...

GHO Capital / Ampersand Capital to acquire Avid Bioservices for $12.50 per share

RBC Capital downgraded Avid Bioservices (CDMO) to Sector Perform from Outperform with a price target of $12.50, up from $12, after the company anno...

Avid Bioservices downgraded to Sector Perform from Outperform at RBC Capital

Craig-Hallum analyst Matt Hewitt maintained a Buy rating on Avid Bioservices (CDMO – Research Report) today. The company's shares closed yesterday ...

Craig-Hallum Sticks to Its Buy Rating for Avid Bioservices (CDMO)

CDMO

HRMY

Pomerantz Law Firm Investigates Claims on Behalf of Investors of Avid Bioservices, Inc. - CDMO

Press Releases

SHAREHOLDER ALERT: Pomerantz Law Firm Investigates Claims on Behalf of Investors of Avid Bioservices, Inc. - CDMO

Avid Bioservices Earns Committed Badge from EcoVadis for Sustainability Performance

Avid Bioservices to Report Financial Results for Quarter and Fiscal Year Ended April 30, 2024, After Market Close on July 2, 2024

Avid Bioservices Reports Financial Results for Fourth Quarter and Fiscal Year Ended April 30, 2024

Avid Bioservices to Report Financial Results for First Quarter of Fiscal Year 2025 After Market Close on September 9, 2024

Avid Bioservices Reports Financial Results for First Quarter Ended July 31, 2024

Avid Bioservices to Participate in Craig-Hallum Bioprocessing Conference

Avid Bioservices to be Acquired by GHO Capital Partners and Ampersand Capital Partners in $1.1 Billion Transaction

Abivax

Allogene Therapeutics, Inc. - Common Stock

Allogene Therapeutics

AnaptysBio

Annexon

Astria Therapeutics

Anavex Life Sciences Corp. - Common Stock

Anavex Life Sciences

Capricor Therapeutics, Inc. - Common Stock

Capricor Therapeutics

Perspective Therapeutics, Inc. Common Stock

Perspective Therapeutics

Dianthus Therapeutics, Inc. - Common Stock

Dianthus Therapeutics

Exscientia Plc - American Depositary Shares

Exscientia

Humacyte

Immunome

Ironwood Pharmaceuticals, Inc. - Class A Common Stock

Ironwood Pharmaceuticals

Mineralys Therapeutics, Inc. - Common Stock

Mineralys Therapeutics

Mereo BioPharma Group plc - American Depositary Shares

Mereo BioPharma Group

Olema Pharmaceuticals, Inc. - Common Stock

Olema Pharmaceuticals

Opthea Limited - American Depositary Shares

Opthea

Oric Pharmaceuticals, Inc. - Common Stock

ORIC Pharmaceuticals

Sana Biotechnology

Silence Therapeutics Plc - American Depository Share

Silence Therapeutics

Stoke Therapeutics

Tectonic Therapeutic, Inc. - Common Stock

Tectonic Therapeutic

Entrada Therapeutics, Inc. - Common Stock

Entrada Therapeutics

Tourmaline Bio

Y-mAbs Therapeutics

RBC Capital

Stephens & Co.

Craig-Hallum

Keybanc

WIIM

Avid Biosciences shares are trading higher after the company announced it agreed to be acquired by GHO Capital Partners and Ampersand in a $1.1 billion transaction. Also, RBC Capital raised its price target on the stock from $12 to $12.5.

Comments

Avid Bioservices

Interés en corto

Avid Bioservices (NASDAQ:CDMO) Bolsa, Informe de interés en corto

La gente también mira

Noticias

SOCIO/CONTRIBUIDOR

BENZINGA GLOBAL